The HIV aspartyl protease inhibitor ritonavir impairs planktonic growth, biofilm formation and proteolytic activity in Trichosporon spp.

References

• Abu-Elteen KH, Hamad MA. 2012. Changing epidemiology of classical and emerging human fungal infections: a review. Jord J Biol Sci. 5:215–230. doi:10.1111/j.1469-0691.2008.01978.x.
   Web of Science ®Google Scholar
• Anil S, Ellepola ANB, Samaranayake LP. 2001. The impact of chlorhexidine gluconate on the relative cell surface hydrophobicity of oral Candida albicans. Oral Dis. 7:119–122. doi:10.1034/j.1601-0825.2001.70210.x.
   PubMed Web of Science ®Google Scholar
• Anitha S, Premamalini T, Kindo AJ. 2015. Virulence factors among Trichosporon species from clinical isolates in a tertiary care centre. Int J Curr Microbiol Appl Sci. 4:493–501.
   Google Scholar
• Bektic J, Lell CP, Fuchs A, Stoiber H, Speth C, Lass-Florl C, Von Zepelin MB, Dierich MP, Wurzner R. 2001. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol Med Microbiol. 31:65–71. doi:10.1111/j.1574-695X.2001.tb01588.x.
   PubMedGoogle Scholar
• Bentubo HDL, Gompertz OF. 2014. Effects of temperature and incubation time on the in vitro expression of proteases, phospholipases, lipases and DNases by different species of Trichosporon. Springer Plus. 3:1–10. doi:10.1186/2193-1801-3-377.
   PubMed Web of Science ®Google Scholar
• Biemann K. 1992. Mass spectrometry of peptides and proteins. Annu Rev Biochem. 61:977–1010. doi:10.1016/j.ymeth.2004.08.013.
   PubMed Web of Science ®Google Scholar
• Borghi E, Sciota R, Biassoni C, Cirasola D, Cappelletti L, Vizzini L, Boracchi P, Morace G. 2011. Cell surface hydrophobicity: a predictor of biofilm production in Candida isolates? J Med Microbiol. 60:689–690. doi:10.1099/jmm.0.026898-0.
   PubMed Web of Science ®Google Scholar
• Braga-Silva AL, Santos ALSA. 2011. Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis. Curr Med Chem. 18:2401–2419. doi:10.2174/092986711795843182.
   PubMed Web of Science ®Google Scholar
• Brilhante RSN, Caetano EP, Riello GB, Guedes GMM, Castelo-Branco DSCM, Fechine MAB, Oliveira JS, Camargo ZP, Mesquita JRL, Monteiro AJ, et al. 2016. Antiretroviral drugs saquinavir and ritonavir reduce inhibitory concentration values of itraconazole against Histoplasma capsulatum strains in vitro. Braz J Infect Dis. 20:155–159. doi:10.1016/j.bjid.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Bujdáková H, Didiášová M, Drahovská H, Černáková L. 2013. Role of cell surface hydrophobicity in Candida albicans biofilm. Cent Eur J Biol. 8:259–262.
   Google Scholar
• Cassone A, Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis. 180:448–453. doi:10.1086/jid.1999.180.issue-2.10.1086/jid.1999.180.issue-2
   PubMed Web of Science ®Google Scholar
• Charney J, Tomarelli RMA. 1947. Colorimetric method for the determination of the proteolytic activity of duodenal juice. J Biol Chem. 171:501–505.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standard Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts Approved Standard M27-A3. Wayne (PA): Clinical and Laboratory Standards.
   Google Scholar
• Collins TJ. 2007. ImageJ for microscopy. Biotechniques. 43:S25–S30. doi:10.2144/000112517.
   PubMed Web of Science ®Google Scholar
• Cong L, Liao Y, Yang S, Yang R. 2017. In vitro activity of berberine alone and in combination with antifungal drugs against planktonic forms and biofilms of Trichosporon asahii. Mycopathologia. doi:10.1007/s11046-017-0119-7.
   PubMedGoogle Scholar
• Cordeiro RA, Serpa R, Alexandre CFU, Marques FJF, Melo CVS, Franco JSF, Evangelista AJJ, Camargo ZP, Brilhante RSN, Rocha MFG, et al. 2015. Trichosporon inkin biofilms produce extracellular proteases and exhibit resistance to antifungals. J Med Microbiol. 64:1277–1286. doi:10.1099/jmm.0.000159.
   PubMed Web of Science ®Google Scholar
• Costa TOG, Almeida RA, Melo JT, Koolen HHF, Silva FMA, Leite JRSA, Prates MV, Bloch JrC, Pinto AC. 2012. Isolation and amino acid sequencing by MALDI-TOF-MS/MS of a novel antimicrobial anionic peptide from the skin secretion of Osteocephalus taurinus (Anura, Hylidae). J Braz Chem Soc. 23:2133–2136. doi:10.1590/S0103-50532012001200002.
   Web of Science ®Google Scholar
• Cuenca-Estrella M, Diaz-Guerra TM, Mellado E, Rodriguez-Tudella JL. 2001. Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp. J Clin Microbiol. 39:525–532. doi:10.1128/JCM.39.2.525-532.2001.
   PubMed Web of Science ®Google Scholar
• De Hoog GS, Guarro J, Gené J, Figueiras MJ. 2000. Atlas of clinical fungi. 2nd ed. Spain: Universitat Rovira i Virgilli.
   Google Scholar
• Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R. 2006. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture and antifungal resistance. Antimicrob Agents Chemother. 50:3269–3276. doi:10.1128/AAC.00556-06.
   PubMed Web of Science ®Google Scholar
• Flexner C. 1998. HIV-protease inhibitors. New Engl. J Med. 338:1281–1293. doi:10.1056/nejm199804303381808.
   Google Scholar
• Gropp K, Schild L, Schindler S, Hube B, Zipfel PF, Skerka C. 2009. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol. 47:465–475. doi:10.1016/j.molimm.2009.08.019.
   PubMed Web of Science ®Google Scholar
• Gross JW, Kan VL. 2008. Trichosporon asahii infection in an advanced AIDS patient and literature review. AIDS. 22:793–795. doi:10.1097/QAD.0b013e3282f51ecc.
   PubMed Web of Science ®Google Scholar
• Hazen KC, Hazen BW. 1993. Surface hydrophobic and hydrophilic protein alterations in Candida albicans. FEMS Microbiol Lett. 107:83–87. doi:10.1111/fml.1993.107.issue-1.10.1111/fml.1993.107.issue-1
   PubMed Web of Science ®Google Scholar
• Iturrieta-González IA, Padovan ACB, Bizerra FC, Hahn RC, Colombo AL. 2014. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. PLoS ONE. 9:1–10. doi:10.1371/journal.pone.0109553.
   Web of Science ®Google Scholar
• Korting HC, Schaller M, Eder G, Hamm G, Bohmer U, Hube B. 1999. Effects of the Human Immunodeficiency Virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother. 43:2038–2042.
   PubMed Web of Science ®Google Scholar
• Liao Y, Yang S, Cong L, Lu X, Ao J, Yang R. 2014. In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates. Antimicrob Agents Chemother. 58:7615–7616. doi:10.1128/AAC.03817-14.
   PubMed Web of Science ®Google Scholar
• Liao Y, Zhao H, Lu X, Yang S, Zhou J, Yang R. 2015. Efficacy of ethanol against Trichosporon asahii biofilm in vitro. Med Mycol. 53:396–404. doi:10.1093/mmy/myv006.
   PubMed Web of Science ®Google Scholar
• Melo NR, Vilela MMS, Junior JJ, Kamei K, Miyaji M, Fukushima K, Nishimura K, Groeneveld P, Kelly SL, Taguchi H. 2006. HIV-1 anti-retroviral drug effect on the C. albicans hyphal growth rate by a bio-cell tracer system. Braz J Microbiol. 37:225–229. doi:10.1590/S1517-83822006000300006.
   Web of Science ®Google Scholar
• Miceli MH, Díaz JA, Lee SA. 2011. Emerging opportunistic yeast infections. Lancet Infect Dis. 11:142–151. doi:10.1016/S1473-3099(10)70218-8.
   PubMed Web of Science ®Google Scholar
• Migliorati CA, Birman EG, Cury AE, Lauderdale F. 2004. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 98:301–310. doi:10.1016/j.tripleo.2004.05.017.
   PubMed Web of Science ®Google Scholar
• Minkiewicz P, Dziuba J, Iwaniak A, Dziuba M, Darewicz M. 2008. BIOPEP database and other programs for processing bioactive peptide sequences. J AOAC Int. 91:965–980.
   PubMed Web of Science ®Google Scholar
• Monari C, Pericolini E, Bistoni G, Cenci E, Bistoni F, Vecchiarelli A. 2005. Influence of indinavir on virulence and growth of Cryptococcus neoformans. J Infect Dis. 191:307–311. doi:10.1086/426828.
   PubMed Web of Science ®Google Scholar
• Montoya AM, González AS, Palma-Nicolás JP, Gómez-Treviño A, González JG, González GM. 2015. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients. Med Mycol. 53:505–511. doi:10.1093/mmy/myv009.
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QW, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 148:126–138. doi:10.1016/j.cell.2011.10.048.
   PubMed Web of Science ®Google Scholar
• Odds FC. 2003. Synergy, antagonism, and what the checkerboard puts between them. J Antimicrob Chemother. 52:1–1. doi:10.1093/jac/dkg301.
   PubMed Web of Science ®Google Scholar
• Palmeira VV, Kneipp LF, Rozental S, Alviano CS, Santos ALS. 2008. Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence. PLoS ONE. 3:1–12. doi:10.1371/journal.pone.0003382.
   Web of Science ®Google Scholar
• Pierce CG, Chaturvedi AK, Lazzell AL, Powell AT, Saville SP, Mchardy SF, Lopez-Ribot JL. 2015. A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. NPJ Biofilms Microbiomes. 1:1–8. doi:10.1038/npjbiofilms.2015.12.
   Google Scholar
• Pietrella D, Rachini A, Pandey N, Schild L, Netea M, Bistoni F, Hube B, Vecchiarelli A. 2010. The inflammatory response induce by aspartic proteases of Candida albicansis independet of proteolytic activity. Infect Immun. 78:4754–4762. doi:10.1128/IAI.00789-10.
   PubMed Web of Science ®Google Scholar
• Ramage G, Rajendran R, Sherry L, Williams C. 2012. Fungal biofilm resistance. Int J Microbiol. 2012:1–14. doi:10.1155/2012/528521.
   Google Scholar
• Roach PL, Clifton IJ, Hensgens CM, Shibata N, Schofield CJ, Hajdu J, Baldwin JE. 1997. Structure of isopenicillin N synthase complexed with substrate and the mechanism of penicillin formation. Nature. 387:827–830. doi:10.1038/42990.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, Gomez-Lopez A, Rodero L, Cuenca-Estrella M. 2005. Susceptibility patterns and molecular identification of Trichosporon Species. Antimicrob Agents Chemother. 49:4026–4034. doi:10.1128/AAC.49.10.4026-4034.2005.
   PubMed Web of Science ®Google Scholar
• Roman AD, Salvaña EM, Guzman-Peñamora MA, Roxas EA, Leyritana KT, Saniel MC. 2014. Invasive trichosporonosis in an AIDS patient: case report and review of the literature. Int J STD AIDS. 25:70–75. doi:10.1177/0956462413487716.
   PubMed Web of Science ®Google Scholar
• Ruan SY, Chien JY, Hsueh PR. 2009. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis. 49:e11–e17. doi:10.1086/599614.
   PubMed Web of Science ®Google Scholar
• Santos ALS. 2010. HIV aspartyl protease inhibitors as promising compounds against Candida albicans. World J Biol Chem. 1:21–30. doi:10.4331/wjbc.v1.i2.21.
   PubMedGoogle Scholar
• Santos ALS, Braga-Silva LA. 2013. Aspartic protease inhibitors: effective drugs against the human fungal pathogen Candida albicans. Mini-Rev Med Chem. 13:155–162. doi:10.2174/1389557511307010155.
   PubMed Web of Science ®Google Scholar
• Sidrim JJC, Perdigão-Neto LV, Cordeiro RA, Brilhante RSN, Leite JJG, Teixeira CEC, Monteiro AJ, Freitas RMF, Ribeiro JF, Mesquita JLR, et al. 2012. Viral protease inhibitors affect the production of virulence factors in Cryptococcus neoformans. Can J Microbiol. 58:932–936. doi:10.1139/w2012-075.
   PubMed Web of Science ®Google Scholar
• Silvestre Junior AM, Miranda MABR, Camargo ZP. 2010. Trichosporon species isolated from the perigenital region, urine and catheters of a brazilian population. Braz J Microbiol. 41:628–634. doi:10.1590/S1517-83822010000300013.
   PubMed Web of Science ®Google Scholar
• Sun W, Su J, Xu S, Yan D. 2012. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol. 61:1750–1757. doi:10.1099/jmm.0.049817-0.
   PubMed Web of Science ®Google Scholar
• Tsai MS, Yang YL, Wang AH, Wang LS, Lu DCT, Liou CH, Hsieh LY, Wu CJ, Cheng MF, Shi ZY, Lo HJ. 2012. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia. 174:121–130. doi:10.1007/s11046-012-9525-z.
   PubMed Web of Science ®Google Scholar
• Tsang CS, Hong I. 2010. HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces. Mycoses. 53:488–494. doi:10.1111/j.1439-0507.2009.01743.x.
   PubMed Web of Science ®Google Scholar
• Von Zepelin MB, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A, Monod M. 1999. HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Investig Dermatol. 113:747–751. doi:10.1046/j.1523-1747.1999.00747.x.10.1046/j.1523-1747.1999.00747.x
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect. 10:48–66. doi:10.1111/j.1470-9465.2004.00839.x.
   PubMed Web of Science ®Google Scholar
• Winter MB, Salcedo EC, Lohse MB, Hartooni N, Gulati M, Sanchez H, Takagi J, Hube B, Andes DR, Johnson AD et al. 2016. Global identification of biofilm specific proteolysis in Candida albicans. mBio. 7: 1–13. doi: 10.1128/mBio.01514-16
   Web of Science ®Google Scholar
• Yang RY, Li HT, Zhu H, Zhou GP, Wang M, Wang L. 2012. Genome sequence of the Trichosporon asahii environmental strain CBS 8904. Eukaryot Cell. 11:15867. doi:10.1128/EC.00264-12.
   Web of Science ®Google Scholar
• Yang S, Liao Y, Cong L, Lu X, Yang R. 2016. In vitro interactions between non-steroidal anti-inflammatory drugs and antifungal agents against planktonic and biofilm forms of Trichosporon asahii. PLoS ONE. 11:1–12. doi:10.1371/journal.pone.0157047.
   Web of Science ®Google Scholar
• Zarnowski R, Sanchez H, Andes DR. 2016. Large-scale production and isolation of Candida biofilm extra cellular matrix. Nat Protoc. 11:2320–2327. doi:10.1038/nprot.2016.132.
   PubMed Web of Science ®Google Scholar
• Zhu W, Filler SG. 2010. Interactions of Candida albicans with epithelial cells. Cell Microbiol. 12:273–282. doi:10.1111/j.1462-5822.2009.01412.x.
   PubMed Web of Science ®Google Scholar